Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25539522
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Circulation
2014 ; 130
(25
): 2343-8
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Duration of anticoagulation for venous thromboembolic events
#MMPMID25539522
Smilowitz NR
; Mega JL
; Berger JS
Circulation
2014[Dec]; 130
(25
): 2343-8
PMID25539522
show ga
A 68 year-old woman with a history of hypertension, hyperlipidemia, and
diverticulitis presents to your office for follow-up care. Three months ago, she
developed 3 days of pain and swelling in her right calf and thigh. Lower
extremity venous ultrasonography demonstrated a deep vein thrombosis in the right
femoral vein. No identifiable cause was noted. She was started on therapeutic
enoxaparin as a bridge to warfarin anticoagulation for idiopathic venous
thromboembolism. Since discharge, her international normalized ratio (INR) has
been maintained between 2 and 3. She has no history of prior bleeding or
thromboembolic events. She wants to know how long to continue anticoagulation,
and what she can do to minimize her risk of recurrent venous thromboembolism.
|*Evidence-Based Medicine
[MESH]
|Aged
[MESH]
|Anticoagulants/*therapeutic use
[MESH]
|Female
[MESH]
|Humans
[MESH]
|Platelet Aggregation Inhibitors/*therapeutic use
[MESH]
|Recurrence
[MESH]
|Time Factors
[MESH]
|Venous Thromboembolism/*drug therapy/prevention & control
[MESH]